ANI Pharmaceuticals ANIP Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from ANI Pharmaceuticals’s reported figures.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's free cash flow?
- ANI Pharmaceuticals (ANIP) reported free cash flow of $52.3M in Q1 2026.
- How has ANI Pharmaceuticals's free cash flow changed year-over-year?
- ANI Pharmaceuticals's free cash flow increased by 60.8% year-over-year, from $32.52M to $52.3M.
- What is the long-term trend for ANI Pharmaceuticals's free cash flow?
- Over 3 years (2022 to 2025), ANI Pharmaceuticals's free cash flow has grown at a 60.8% compound annual growth rate (CAGR), from -$41.23M to $171.39M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.